Stocksigma LogoStocksigma Logo

Invicta Diagnostic H1 FY27 Results and Acquisition Deferral

Invicta Diagnostic reported consolidated revenue from operations of ₹2,424.65 lakhs for the half year ended 30th Sep'26, up 43.1% YoY from ₹1,694.73 lakhs

Invicta Diagnostic H1 FY27 Results and Acquisition Deferral

Invicta Diagnostic Ltd · Outcome · 15 Nov 2026, 1:59 am

Invicta Diagnostic H1 FY27 Results and Acquisition Deferral Invicta Diagnostic reported consolidated revenue from operations of ₹2,424.65 lakhs for the half year ended 30th Sep'26, up 43.1% YoY from ₹1,694.73 lakhs. Consolidated net profit fell 43.2% YoY to ₹232.14 lakhs from ₹408.41 lakhs, with basic EPS at ₹2.01 versus ₹4.59. Standalone revenue reached ₹1,379.11 lakhs with net profit of ₹388.40 lakhs. Additionally, the Board deferred the acquisition proposal for diagnostic centre businesses in Nashik through a subsidiary to a separate meeting. IPO fund deployment reached ₹1,446.69 lakhs out of ₹2,533.89 lakhs available.

Original exchange filing (PDF)

More announcements from Invicta Diagnostic Ltd

All Invicta Diagnostic Ltd announcements